VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,210 | +75.0% | 15,987 | +95.8% | 0.03% | +81.2% |
| Q2 2023 | $245,818 | -27.9% | 8,164 | -8.2% | 0.02% | -40.7% |
| Q1 2022 | $341,000 | +711.9% | 8,895 | +294.6% | 0.03% | +68.8% |
| Q3 2018 | $42,000 | -88.8% | 2,254 | -86.6% | 0.02% | -88.3% |
| Q2 2018 | $374,000 | +50.8% | 16,772 | +48.9% | 0.14% | +59.3% |
| Q1 2018 | $248,000 | -99.9% | 11,262 | +13.1% | 0.09% | -4.4% |
| Q3 2017 | $228,544,000 | – | 9,954 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |